Correlation Between Merck and 632525AW1
Specify exactly 2 symbols:
By analyzing existing cross correlation between Merck Company and NAB 2648 14 JAN 41, you can compare the effects of market volatilities on Merck and 632525AW1 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of 632525AW1. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and 632525AW1.
Diversification Opportunities for Merck and 632525AW1
Excellent diversification
The 3 months correlation between Merck and 632525AW1 is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and NAB 2648 14 JAN 41 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NAB 2648 14 and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with 632525AW1. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NAB 2648 14 has no effect on the direction of Merck i.e., Merck and 632525AW1 go up and down completely randomly.
Pair Corralation between Merck and 632525AW1
Considering the 90-day investment horizon Merck Company is expected to under-perform the 632525AW1. In addition to that, Merck is 1.28 times more volatile than NAB 2648 14 JAN 41. It trades about -0.19 of its total potential returns per unit of risk. NAB 2648 14 JAN 41 is currently generating about -0.12 per unit of volatility. If you would invest 7,143 in NAB 2648 14 JAN 41 on September 22, 2024 and sell it today you would lose (222.00) from holding NAB 2648 14 JAN 41 or give up 3.11% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 42.19% |
Values | Daily Returns |
Merck Company vs. NAB 2648 14 JAN 41
Performance |
Timeline |
Merck Company |
NAB 2648 14 |
Merck and 632525AW1 Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Merck and 632525AW1
The main advantage of trading using opposite Merck and 632525AW1 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, 632525AW1 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 632525AW1 will offset losses from the drop in 632525AW1's long position.Merck vs. Emergent Biosolutions | Merck vs. Neurocrine Biosciences | Merck vs. Teva Pharma Industries | Merck vs. Haleon plc |
632525AW1 vs. AEP TEX INC | 632525AW1 vs. US BANK NATIONAL | 632525AW1 vs. Republic Bancorp | 632525AW1 vs. BYD Co Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |